Kuo HT

References (18)

Title : Harnessing Contact-Quenched, Profluorescent Chemical Probes for Sensitive Determination and High-Throughput Measurements of Enzyme Activity - Huang_2025_ACS.Omega_10_58566
Author(s) : Huang CH , Dai CY , Wang SH , Severance S , Hwang CC , Liu YC , Yeh BL , Weng YC , Yu SL , Kuo HT , Wang LF , Wang JJ , Wang TP
Ref : ACS Omega , 10 :58566 , 2025
Abstract :
PubMedSearch : Huang_2025_ACS.Omega_10_58566
PubMedID: 41502669

Title : Harnessing Contact-Quenched, Profluorescent Chemical Probes for Sensitive Determination and High-Throughput Measurements of Enzyme Activity - Huang_2025_ACS.Omega_10_58566
Author(s) : Huang CH , Dai CY , Wang SH , Severance S , Hwang CC , Liu YC , Yeh BL , Weng YC , Yu SL , Kuo HT , Wang LF , Wang JJ , Wang TP
Ref : ACS Omega , 10 :58566 , 2025
Abstract :
PubMedSearch : Huang_2025_ACS.Omega_10_58566
PubMedID: 41502669

Title : Harnessing Contact-Quenched, Profluorescent Chemical Probes for Sensitive Determination and High-Throughput Measurements of Enzyme Activity - Huang_2025_ACS.Omega_10_58566
Author(s) : Huang CH , Dai CY , Wang SH , Severance S , Hwang CC , Liu YC , Yeh BL , Weng YC , Yu SL , Kuo HT , Wang LF , Wang JJ , Wang TP
Ref : ACS Omega , 10 :58566 , 2025
Abstract :
PubMedSearch : Huang_2025_ACS.Omega_10_58566
PubMedID: 41502669

Title : Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study - Kuo_2024_Hepatol.Int__
Author(s) : Kuo CC , Chuang MH , Li CH , Huang PY , Kuo HT , Lai CC
Ref : Hepatol Int , : , 2024
Abstract :
PubMedSearch : Kuo_2024_Hepatol.Int__
PubMedID: 39602049

Title : Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-alpha-targeted radiotheranostic for cancer imaging and therapy - Bendre_2024_Eur.J.Med.Chem_268_116238
Author(s) : Bendre S , Merkens H , Kuo HT , Ng P , Wong A , Lau WS , Zhang Z , Kurkowska S , Chen CC , Uribe C , Benard F , Lin KS
Ref : Eur Journal of Medicinal Chemistry , 268 :116238 , 2024
Abstract :
PubMedSearch : Bendre_2024_Eur.J.Med.Chem_268_116238
PubMedID: 38367492
Gene_locus related to this paper: human-FAP

Title : Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-alpha-targeted radiotheranostic for cancer imaging and therapy - Bendre_2024_Eur.J.Med.Chem_268_116238
Author(s) : Bendre S , Merkens H , Kuo HT , Ng P , Wong A , Lau WS , Zhang Z , Kurkowska S , Chen CC , Uribe C , Benard F , Lin KS
Ref : Eur Journal of Medicinal Chemistry , 268 :116238 , 2024
Abstract :
PubMedSearch : Bendre_2024_Eur.J.Med.Chem_268_116238
PubMedID: 38367492
Gene_locus related to this paper: human-FAP

Title : Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study - Kuo_2024_Hepatol.Int__
Author(s) : Kuo CC , Chuang MH , Li CH , Huang PY , Kuo HT , Lai CC
Ref : Hepatol Int , : , 2024
Abstract :
PubMedSearch : Kuo_2024_Hepatol.Int__
PubMedID: 39602049

Title : Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-alpha-targeted radiotheranostic for cancer imaging and therapy - Bendre_2024_Eur.J.Med.Chem_268_116238
Author(s) : Bendre S , Merkens H , Kuo HT , Ng P , Wong A , Lau WS , Zhang Z , Kurkowska S , Chen CC , Uribe C , Benard F , Lin KS
Ref : Eur Journal of Medicinal Chemistry , 268 :116238 , 2024
Abstract :
PubMedSearch : Bendre_2024_Eur.J.Med.Chem_268_116238
PubMedID: 38367492
Gene_locus related to this paper: human-FAP

Title : Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study - Kuo_2024_Hepatol.Int__
Author(s) : Kuo CC , Chuang MH , Li CH , Huang PY , Kuo HT , Lai CC
Ref : Hepatol Int , : , 2024
Abstract :
PubMedSearch : Kuo_2024_Hepatol.Int__
PubMedID: 39602049

Title : Novel (68)Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast - Verena_2023_Pharmaceuticals.(Basel)_16_
Author(s) : Verena A , Kuo HT , Merkens H , Zeisler J , Bendre S , Wong A , Benard F , Lin KS
Ref : Pharmaceuticals (Basel) , 16 : , 2023
Abstract :
PubMedSearch : Verena_2023_Pharmaceuticals.(Basel)_16_
PubMedID: 36986548

Title : Manipulating Diastereomeric Bicyclononynes to Sensitively Determine Enzyme Activity and Facilitate Macromolecule Conjugations - Huang_2023_ACS.Omega_8_46073
Author(s) : Huang CH , Hou SY , Severance S , Hwang CC , Fang BK , Gong MM , Yu SL , Weng YC , Wang LF , Dai CY , Wang SH , Kuo HT , Wang JJ , Wang TP
Ref : ACS Omega , 8 :46073 , 2023
Abstract :
PubMedSearch : Huang_2023_ACS.Omega_8_46073
PubMedID: 38075741

Title : Manipulating Diastereomeric Bicyclononynes to Sensitively Determine Enzyme Activity and Facilitate Macromolecule Conjugations - Huang_2023_ACS.Omega_8_46073
Author(s) : Huang CH , Hou SY , Severance S , Hwang CC , Fang BK , Gong MM , Yu SL , Weng YC , Wang LF , Dai CY , Wang SH , Kuo HT , Wang JJ , Wang TP
Ref : ACS Omega , 8 :46073 , 2023
Abstract :
PubMedSearch : Huang_2023_ACS.Omega_8_46073
PubMedID: 38075741

Title : Synthesis and Preclinical Evaluation of Novel (68)Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging - Bendre_2023_Pharmaceuticals.(Basel)_16_798
Author(s) : Bendre S , Kuo HT , Merkens H , Zhang Z , Wong A , Benard F , Lin KS
Ref : Pharmaceuticals (Basel) , 16 :798 , 2023
Abstract :
PubMedSearch : Bendre_2023_Pharmaceuticals.(Basel)_16_798
PubMedID: 37375746
Gene_locus related to this paper: human-FAP

Title : Novel (68)Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast - Verena_2023_Pharmaceuticals.(Basel)_16_
Author(s) : Verena A , Kuo HT , Merkens H , Zeisler J , Bendre S , Wong A , Benard F , Lin KS
Ref : Pharmaceuticals (Basel) , 16 : , 2023
Abstract :
PubMedSearch : Verena_2023_Pharmaceuticals.(Basel)_16_
PubMedID: 36986548

Title : Synthesis and Preclinical Evaluation of Novel (68)Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging - Bendre_2023_Pharmaceuticals.(Basel)_16_798
Author(s) : Bendre S , Kuo HT , Merkens H , Zhang Z , Wong A , Benard F , Lin KS
Ref : Pharmaceuticals (Basel) , 16 :798 , 2023
Abstract :
PubMedSearch : Bendre_2023_Pharmaceuticals.(Basel)_16_798
PubMedID: 37375746
Gene_locus related to this paper: human-FAP

Title : Novel (68)Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast - Verena_2023_Pharmaceuticals.(Basel)_16_
Author(s) : Verena A , Kuo HT , Merkens H , Zeisler J , Bendre S , Wong A , Benard F , Lin KS
Ref : Pharmaceuticals (Basel) , 16 : , 2023
Abstract :
PubMedSearch : Verena_2023_Pharmaceuticals.(Basel)_16_
PubMedID: 36986548

Title : Synthesis and Preclinical Evaluation of Novel (68)Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging - Bendre_2023_Pharmaceuticals.(Basel)_16_798
Author(s) : Bendre S , Kuo HT , Merkens H , Zhang Z , Wong A , Benard F , Lin KS
Ref : Pharmaceuticals (Basel) , 16 :798 , 2023
Abstract :
PubMedSearch : Bendre_2023_Pharmaceuticals.(Basel)_16_798
PubMedID: 37375746
Gene_locus related to this paper: human-FAP

Title : Manipulating Diastereomeric Bicyclononynes to Sensitively Determine Enzyme Activity and Facilitate Macromolecule Conjugations - Huang_2023_ACS.Omega_8_46073
Author(s) : Huang CH , Hou SY , Severance S , Hwang CC , Fang BK , Gong MM , Yu SL , Weng YC , Wang LF , Dai CY , Wang SH , Kuo HT , Wang JJ , Wang TP
Ref : ACS Omega , 8 :46073 , 2023
Abstract :
PubMedSearch : Huang_2023_ACS.Omega_8_46073
PubMedID: 38075741